JSE set for second day of gains on virus treatment news
Global equities rallied on news that the US Food and Drug Administration authorised the use of blood plasma as a treatment for Covid-19
24 August 2020 - 12:36
The JSE was on track for its second day of gains on Monday as developments in the search for a coronavirus treatment boosted risk appetite.
Global equities rallied on news that the US Food and Drug Administration authorised the use of blood plasma as a treatment for Covid-19 patients. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.